Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Rheumatoid Arthritis

Free Subscription Articles published in Scand J Rheumatol Retrieve available abstracts of 59 articles: HTML format

Single Articles

March 2023
1. RASMUSSEN SL, Strandbygaard LL, Fuursted K, Kragholm KH, et al
   Antibody response in patients with autoimmune inflammatory rheumatic disease after pneumococcal polysaccharide prime vaccination or revaccination.
   Scand J Rheumatol. 2023;52:174-180.
   PubMed     Abstract available
   
   
   
2. OLSSON P, Ekblad F, Hassler A, Bengtsson M, et al
   Complications after minor salivary gland biopsy: a retrospective study of 630 patients from two Swedish centres.
   Scand J Rheumatol. 2023;52:208-216.
   PubMed     Abstract available
   
   
   
3. YU X, Zhu F, Yu X, Wang J, et al
   Serum CCL28 as a biomarker for diagnosis and evaluation of Sjogren's syndrome.
   Scand J Rheumatol. 2023;52:200-207.
   PubMed     Abstract available
   
   
   February 2023
4. KARLSSON ML, Hertzberg-Nyquist K, Saevarsdottir S, Lundberg IE, et al
   Evaluation of an individually tailored smoking-cessation intervention for patients with rheumatoid arthritis in an outpatient clinic.
   Scand J Rheumatol. 2023 Feb 23:1-11. doi: 10.1080/03009742.2023.2172903.
   PubMed     Abstract available
   
   
   
5. LANDGREN AJ, Klingberg E, Jacobsson L, Bergsten U, et al
   Health-related quality of life in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis, results from a cross-sectional survey in Western Sweden.
   Scand J Rheumatol. 2023 Feb 6:1-13. doi: 10.1080/03009742.2022.2157962.
   PubMed     Abstract available
   
   
   January 2023
6. KOERS J, Derksen N, Falkenburg W, Ooijevaar-de Heer P, et al
   Elevated Fab glycosylation of anti-hinge antibodies.
   Scand J Rheumatol. 2023;52:25-32.
   PubMed     Abstract available
   
   
   November 2022
7. LIAO HT, Tung HY, Chou CT, Tsai HC, et al
   Immunogenicity of the mRNA-1273 and ChAdOx1 nCoV-19 vaccines in Asian patients with autoimmune rheumatic diseases under biologic and/or conventional immunosuppressant treatments.
   Scand J Rheumatol. 2022;51:500-505.
   PubMed     Abstract available
   
   
   October 2022
8. RASMUSSEN EB, Thiele LS, Stengaard-Pedersen K, Hetland ML, et al
   Baseline serum levels of IgA anti-cyclic citrullinated protein antibodies in early rheumatoid arthritis predict radiographic progression after 11 years of treatment: a secondary analysis of the CIMESTRA study.
   Scand J Rheumatol. 2022 Oct 18:1-5. doi: 10.1080/03009742.2022.2127245.
   PubMed     Abstract available
   
   
   September 2022
9. SIMONS G, Scholin Bywall K, Englbrecht M, Johansson EC, et al
   Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis.
   Scand J Rheumatol. 2022 Sep 30:1-11. doi: 10.1080/03009742.2022.2116805.
   PubMed     Abstract available
   
   
   
10. VAN BOHEEMEN L, Ter Wee MM, Falahee M, Filer A, et al
    The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development.
    Scand J Rheumatol. 2022 Sep 29:1-8. doi: 10.1080/03009742.2022.2116806.
    PubMed     Abstract available
    
    
    July 2022
11. HU H, Wang S
    Rheumatoid arthritis with coral reef aorta: a case report.
    Scand J Rheumatol. 2022 Jul 14:1-2. doi: 10.1080/03009742.2022.2082150.
    PubMed    
    
    
    
12. RAFT MB, Hetland ML, Brahe CH, Horslev-Petersen K, et al
    Serum 14-3-3eta as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.
    Scand J Rheumatol. 2022 Jul 14:1-11. doi: 10.1080/03009742.2022.2087900.
    PubMed     Abstract available
    
    
    
13. CHEN D, Yin H, Tang G, Lu L, et al
    Efficacy of low-dose of baricitinib in the treatment of patchy alopecia and sicca syndrome in an SLE patient.
    Scand J Rheumatol. 2022 Jul 14:1-3. doi: 10.1080/03009742.2022.2087901.
    PubMed    
    
    
    
14. KRIJBOLDER DI, Verstappen M, Wouters F, Lard LR, et al
    Comparison between 1.5T and 3.0T MRI: both field strengths sensitively detect subclinical inflammation of hand and forefoot in patients with arthralgia.
    Scand J Rheumatol. 2022;51:284-290.
    PubMed     Abstract available
    
    
    June 2022
15. ZHANG K, Jia Y, Wang R, Guo D, et al
    Rheumatoid arthritis and the risk of major cardiometabolic diseases: a Mendelian randomization study.
    Scand J Rheumatol. 2022 Jun 6:1-7. doi: 10.1080/03009742.2022.2070988.
    PubMed     Abstract available
    
    
    May 2022
16. VENETSANOPOULOU AI, Alamanos Y, Skalkou A, Voulgari PV, et al
    The changing incidence of rheumatoid arthritis over time in north-west Greece: data from a referral centre.
    Scand J Rheumatol. 2022 May 12:1-8. doi: 10.1080/03009742.2022.2058178.
    PubMed     Abstract available
    
    
    
17. LEE NY, Kim NR, Kang JW, Kim G, et al
    Increased salivary syndecan-1 level is associated with salivary gland function and inflammation in patients with Sjogren's syndrome.
    Scand J Rheumatol. 2022;51:220-229.
    PubMed     Abstract available
    
    
    
18. FOHSE FK, Rollefstad S, Ikdahl E, Wibetoe G, et al
    Degree of arterial stiffness is comparable across inflammatory joint disease entities.
    Scand J Rheumatol. 2022;51:186-195.
    PubMed     Abstract available
    
    
    April 2022
19. DIEPERINK SS, Glintborg B, Oestergaard LB, Norgaard M, et al
    Risk of Staphylococcus aureus bacteraemia in patients with rheumatoid arthritis and the effect of orthopaedic implants on the risk: a nationwide observational cohort study.
    Scand J Rheumatol. 2022 Apr 20:1-9. doi: 10.1080/03009742.2022.2049057.
    PubMed     Abstract available
    
    
    March 2022
20. HESLINGA M, Teunissen C, Agca R, van der Woude D, et al
    NT-proBNP and sRAGE levels in early rheumatoid arthritis.
    Scand J Rheumatol. 2022 Mar 11:1-7. doi: 10.1080/03009742.2022.2042975.
    PubMed     Abstract available
    
    
    
21. ALSING CL, Nystad TW, Igland J, Gjesdal CG, et al
    Trends in the occurrence of ischaemic heart disease over time in rheumatoid arthritis: 1821 patients from 1972 to 2017.
    Scand J Rheumatol. 2022 Mar 11:1-10. doi: 10.1080/03009742.2022.2040116.
    PubMed     Abstract available
    
    
    
22. RUWAARD J, L' Ami MJ, Kneepkens EL, Krieckaert C, et al
    Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial.
    Scand J Rheumatol. 2022 Mar 2:1-8. doi: 10.1080/03009742.2022.2028364.
    PubMed     Abstract available
    
    
    
23. LIU Y, Wang Z, Ren L, Zeng Q, et al
    Sonographic findings of immunoglobulin G4-related sialadenitis and differences from Sjogren's syndrome.
    Scand J Rheumatol. 2022;51:128-134.
    PubMed     Abstract available
    
    
    January 2022
24. SKOVSGAARD CV, Kruse M, Hjollund N, Maribo T, et al
    Cost-effectiveness of a telehealth intervention in rheumatoid arthritis: economic evaluation of the Telehealth in RA (TeRA) randomized controlled trial.
    Scand J Rheumatol. 2022 Jan 20:1-11. doi: 10.1080/03009742.2021.2008604.
    PubMed     Abstract available
    
    
    
25. NIELSEN MA, Koster D, Greisen S, Troldborg A, et al
    Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2022 Jan 13:1-9. doi: 10.1080/03009742.2021.1992860.
    PubMed     Abstract available
    
    
    
26. MOLANDER V, Bower H, Askling J
    Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis.
    Scand J Rheumatol. 2022 Jan 13:1-7. doi: 10.1080/03009742.2021.2001907.
    PubMed     Abstract available
    
    
    
27. GLOYER L, Golumba-Nagy V, Meyer A, Yan S, et al
    Adenosine receptor A2a blockade by caffeine increases IFN-gamma production in Th1 cells from patients with rheumatoid arthritis.
    Scand J Rheumatol. 2022 Jan 13:1-5. doi: 10.1080/03009742.2021.1995956.
    PubMed     Abstract available
    
    
    
28. CARRARA G, Argnani L, Zanetti A, Zabotti A, et al
    Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology.
    Scand J Rheumatol. 2022 Jan 13:1-5. doi: 10.1080/03009742.2021.2003033.
    PubMed     Abstract available
    
    
    
29. KEROLA AM, Rollefstad S, Kazemi A, Wibetoe G, et al
    Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents.
    Scand J Rheumatol. 2022 Jan 11:1-9. doi: 10.1080/03009742.2021.1997436.
    PubMed     Abstract available
    
    
    
30. UHRENHOLT L, Christensen R, Dreyer L, Schlemmer A, et al
    Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study.
    Scand J Rheumatol. 2022;51:25-33.
    PubMed     Abstract available
    
    
    
31. OTTAVIANI S, Khaleche S, Borie R, Debray MP, et al
    Rheumatological evaluation of patients with interstitial lung disease.
    Scand J Rheumatol. 2022;51:34-41.
    PubMed     Abstract available
    
    
    
32. KITADA T, Kadoba K, Watanabe R, Koyama T, et al
    Listeriosis presenting with fever, arthralgia, elevated liver enzymes, and hyperferritinaemia in pregnancy: a critical mimicker of adult-onset Still's disease.
    Scand J Rheumatol. 2022;51:78-80.
    PubMed    
    
    
    December 2021
33. SOUSSI BG, Cordtz RL, Kristensen S, Bork CS, et al
    Incidence and prevalence of rheumatoid arthritis in Denmark from 1998 to 2018: a nationwide register-based study.
    Scand J Rheumatol. 2021 Dec 16:1-9. doi: 10.1080/03009742.2021.1957557.
    PubMed     Abstract available
    
    
    November 2021
34. THOMSEN T, Esbensen BA, Hetland ML, Aadahl M, et al
    Characteristics of participants and decliners from a randomized controlled trial on physical activity in patients with rheumatoid arthritis: a retrospective register-based cross-sectional study.
    Scand J Rheumatol. 2021 Nov 2:1-8. doi: 10.1080/03009742.2021.1975394.
    PubMed     Abstract available
    
    
    
35. GEHIN JE, Warren DJ, Syversen SW, Lie E, et al
    Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study.
    Scand J Rheumatol. 2021;50:445-454.
    PubMed     Abstract available
    
    
    October 2021
36. PALTTA J, Heikkila HK, Pirila L, Eklund KK, et al
    The validity of rheumatoid arthritis diagnoses in Finnish biobanks.
    Scand J Rheumatol. 2021 Oct 13:1-9. doi: 10.1080/03009742.2021.1967047.
    PubMed     Abstract available
    
    
    
37. ANGSTROM L, Hornberg K, Sundstrom B, Sodergren A, et al
    Rheumatoid cachexia in early rheumatoid arthritis: prevalence and associated variables.
    Scand J Rheumatol. 2021 Oct 13:1-7. doi: 10.1080/03009742.2021.1973678.
    PubMed     Abstract available
    
    
    
38. AMRIS K, Bandak E, Kristensen LE, Waehrens EE, et al
    Agreement between self-reported and observed functioning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia, and the influence of pain and fatigue: a cross-sectional study.
    Scand J Rheumatol. 2021 Oct 1:1-9. doi: 10.1080/03009742.2021.1952755.
    PubMed     Abstract available
    
    
    September 2021
39. JENSEN R, Christensen AF, Hartlev LB, Thomsen JS, et al
    Calcified cartilage differs in patients with end-stage primary osteoarthritis and secondary osteoarthritis due to rheumatoid arthritis of the hip joint.
    Scand J Rheumatol. 2021 Sep 13:1-11. doi: 10.1080/03009742.2021.1952754.
    PubMed     Abstract available
    
    
    
40. THOMAS PE, Aarestrup J, Jacobsen S, Jensen BW, et al
    Birthweight, body size, and growth during childhood and risks of rheumatoid arthritis: a large Danish cohort study.
    Scand J Rheumatol. 2021 Sep 13:1-9. doi: 10.1080/03009742.2021.1954772.
    PubMed     Abstract available
    
    
    
41. BERTRAND D, Stouten V, De Cock D, Pazmino S, et al
    Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial.
    Scand J Rheumatol. 2021 Sep 13:1-11. doi: 10.1080/03009742.2021.1955467.
    PubMed     Abstract available
    
    
    
42. MARS N, Kerola AM, Kauppi MJ, Pirinen M, et al
    Cluster analysis identifies unmet healthcare needs among patients with rheumatoid arthritis.
    Scand J Rheumatol. 2021 Sep 13:1-8. doi: 10.1080/03009742.2021.1944306.
    PubMed     Abstract available
    
    
    
43. NAKAYAMA Y, Hashimoto M, Watanabe R, Murakami K, et al
    Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study.
    Scand J Rheumatol. 2021 Sep 13:1-10. doi: 10.1080/03009742.2021.1947005.
    PubMed     Abstract available
    
    
    
44. MOLLER-BISGAARD S, Horslev-Petersen K, Ejbjerg B, Hetland ML, et al
    Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.
    Scand J Rheumatol. 2021 Sep 2:1-11. doi: 10.1080/03009742.2021.1935312.
    PubMed     Abstract available
    
    
    
45. ENDO Y, Kawashiri SY, Nishino A, Michitsuji T, et al
    Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan.
    Scand J Rheumatol. 2021 Sep 2:1-9. doi: 10.1080/03009742.2021.1927389.
    PubMed     Abstract available
    
    
    
46. ANDERSSON M, Svensson B, Bergman S
    Pain in rheumatoid arthritis: a seven-year follow-up study of pain distribution and factors associated with transition from and to chronic widespread pain.
    Scand J Rheumatol. 2021 Sep 1:1-10. doi: 10.1080/03009742.2021.1944304.
    PubMed     Abstract available
    
    
    
47. CIAFFI J, Giuggioli D, Spinella A, Meliconi R, et al
    Resilience of systemic sclerosis patients following the first COVID-19 wave in Italy.
    Scand J Rheumatol. 2021;50:411-412.
    PubMed    
    
    
    July 2021
48. VUOLTEENAHO K, Tuure L, Nieminen R, Laasonen L, et al
    Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab.
    Scand J Rheumatol. 2021 Jul 15:1-6. doi: 10.1080/03009742.2021.1929456.
    PubMed     Abstract available
    
    
    
49. CAO C, Shao Q, Yang H
    Sjogren's syndrome concurrent with organizing pneumonia with secondary systemic capillary leak syndrome: a case report.
    Scand J Rheumatol. 2021;50:322-324.
    PubMed    
    
    
    June 2021
50. PEDERSEN JK, Andersen K, Svendsen AJ, Horslev-Petersen K, et al
    No difference in antidepressant prescription in rheumatoid arthritis and controls. Results from a population-based, matched inception cohort.
    Scand J Rheumatol. 2021 Jun 29:1-7. doi: 10.1080/03009742.2021.1923148.
    PubMed     Abstract available
    
    
    
51. MCCOY SS, Greenlee RT, VanWormer JJ, Schletzbaum M, et al
    Smoking associated with reduced odds of Sjogren's syndrome among rheumatoid arthritis patients.
    Scand J Rheumatol. 2021 Jun 25:1-5. doi: 10.1080/03009742.2021.1925584.
    PubMed     Abstract available
    
    
    
52. VERSTEEG GA, Steunebrink L, Vonkeman HE, Ten Klooster PM, et al
    Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission.
    Scand J Rheumatol. 2021 Jun 21:1-10. doi: 10.1080/03009742.2021.1917161.
    PubMed     Abstract available
    
    
    
53. TAN YK, Teo P, Saffari SE, Xin X, et al
    A musculoskeletal ultrasound program as an intervention to improve disease modifying anti-rheumatic drugs adherence in rheumatoid arthritis: a randomized controlled trial.
    Scand J Rheumatol. 2021 Jun 10:1-9. doi: 10.1080/03009742.2021.1901416.
    PubMed     Abstract available
    
    
    May 2021
54. SCHAFER C
    Early description of polyarthritis possibly representing rheumatoid arthritis given by a patient, as recorded in a textbook on gout from 1788.
    Scand J Rheumatol. 2021 May 5:1-2. doi: 10.1080/03009742.2021.1894824.
    PubMed    
    
    
    
55. ELOFF E, Martinsson K, Ziegelasch M, Cedergren J, et al
    Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain.
    Scand J Rheumatol. 2021;50:189-197.
    PubMed     Abstract available
    
    
    April 2021
56. GAO J, Xin L, Guo Q, Xu K, et al
    Twenty-year changes in mortality rates and underlying causes of death in patients with rheumatoid arthritis-associated interstitial lung disease.
    Scand J Rheumatol. 2021 Apr 14:1-5. doi: 10.1080/03009742.2021.1882557.
    PubMed     Abstract available
    
    
    March 2021
57. SHAO Q, Wang S, Jiang H, Liu L, et al
    Efficacy and safety of iguratimod on patients with primary Sjogren's syndrome: a randomized, placebo-controlled clinical trial.
    Scand J Rheumatol. 2021;50:143-152.
    PubMed     Abstract available
    
    
    
58. KONONOFF A, Horkko S, Pussinen P, Kautiainen H, et al
    Antibodies to malondialdehyde-acetaldehyde modified low-density lipoprotein in patients with newly diagnosed inflammatory joint disease.
    Scand J Rheumatol. 2021;50:113-117.
    PubMed     Abstract available
    
    
    
59. LAVERE P, Sonkar J, Du X, Qian YW, et al
    Macrophage activation syndrome complicating adult onset Still's disease: a case report.
    Scand J Rheumatol. 2021;50:161-162.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: